Watermark
Go to Asia edition

Rule change spells end to Eu2.8bn DB Novartis bond

  • 27 Jun 2003

Deutsche Bank was forced to redeem a Eu2.8bn exchangeable into Swiss pharmaceuticals giant Novartis this week, following an unexpected change in accounting regulations.

The introduction of a new rule by the Financial Accounting Standards Board over the treatment of hedging practices rendered the Eu3.2bn exchangeable unattractive for Novartis.

Novartis structured the trade through Deutsche ...

Please take a trial or subscribe to access this content.

Contact our subscriptions team to discuss your access: subs@globalcapital.com

Or sign up for a trial to gain full access to the entire site for a limited period.

Free Trial
Log in

Corporate access

To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.

Bond Comments

All International Bonds

Rank Lead Manager Amount $m No of issues Share %
View full table
For detailed analysis: Dealogic
  • Last updated
  • Today
1 Citi 23,474.87 54 9.05%
2 JPMorgan 22,392.03 63 8.64%
3 BNP Paribas 18,479.27 34 7.13%
4 HSBC 16,833.19 48 6.49%
5 Barclays 16,808.93 39 6.48%

Bookrunners of All Syndicated Loans EMEA

Rank Lead Manager Amount $m No of issues Share %
View full table
For detailed analysis: Dealogic
  • Last updated
  • Today
1 BNP Paribas 56,371.71 236 6.78%
2 Credit Agricole CIB 50,115.87 240 6.03%
3 JPMorgan 46,785.38 108 5.63%
4 UniCredit 45,665.76 207 5.50%
5 SG Corporate & Investment Banking 43,321.52 173 5.21%

Bookrunners of all EMEA ECM Issuance

Rank Lead Manager Amount $m No of issues Share %
View full table
For detailed analysis: Dealogic
  • Last updated
  • Today
1 Morgan Stanley 114.77 1 17.52%
1 BNP Paribas 114.77 1 17.52%
3 Commerzbank Group 65.85 2 10.05%
4 Oakley Advisory Ltd 64.52 1 9.85%
4 Barclays 64.52 1 9.85%